The introduction of the 750mcg teriparatide solution in Australia has seen controlled availability to date. Primarily directed for patients with severe osteoporosis who have not responded to other medications, access is selectively managed. Present supply levels are limited, and sufferers should discuss from their physician the recent informatio… Read More